Smorgick Noam
Departments of Obstetrics and Gynecology, Assaf Harofe Medical Center, Affiliated with the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Int J Womens Health. 2017 Mar 23;9:157-161. doi: 10.2147/IJWH.S99993. eCollection 2017.
Minimally invasive hysterectomy via the laparoscopic or vaginal approach is beneficial to patients when compared with laparotomy, but has not been offered in the past to all women because of the technical difficulties and the long learning curve required for laparoscopic hysterectomy. Robotic-assisted hysterectomy for benign indications may allow for a shorter learning curve but does not offer clear advantages over conventional laparoscopic hysterectomy in terms of surgical outcomes. In addition, robotic hysterectomy is invariably associated with increased costs. Nevertheless, this surgical approach has been widely adopted by gynecologic surgeons. The aim of this review is to describe specific indications and patients who may benefit from robotic-assisted hysterectomy. These include hysterectomy for benign conditions in cases with high surgical complexity (such as pelvic adhesive disease and endometriosis), hysterectomy and lymphadenectomy for treatment of endometrial carcinoma, and obese patients. In the future, additional evidence regarding the benefits of single-site robotic hysterectomy may further modify the indications for robotic-assisted hysterectomy.
与剖腹手术相比,经腹腔镜或阴道途径的微创子宫切除术对患者有益,但过去并非所有女性都能接受,因为腹腔镜子宫切除术存在技术困难且学习曲线较长。用于良性指征的机器人辅助子宫切除术可能会缩短学习曲线,但在手术结果方面与传统腹腔镜子宫切除术相比并无明显优势。此外,机器人子宫切除术必然会增加成本。尽管如此,这种手术方法已被妇科外科医生广泛采用。本综述的目的是描述可能从机器人辅助子宫切除术中获益的特定指征和患者。这些包括手术复杂性高的病例(如盆腔粘连性疾病和子宫内膜异位症)的良性疾病子宫切除术、子宫内膜癌治疗的子宫切除术和淋巴结清扫术,以及肥胖患者。未来,关于单孔机器人子宫切除术益处的更多证据可能会进一步改变机器人辅助子宫切除术的指征。